| Title |
The Met tyrosine kinase receptor in development and cancer
|
|---|---|
| Published in |
Cancer and Metastasis Reviews, January 2008
|
| DOI | 10.1007/s10555-007-9107-6 |
| Pubmed ID | |
| Authors |
Alessandra Gentile, Livio Trusolino, Paolo M. Comoglio |
| Abstract |
Met is a tyrosine kinase receptor, encoded by an oncogene, whose crucial role has been elucidated during the last two decades. The complex biological program triggered by Met has been dissected and its biological relevance in both physiology and pathology has been proven. Met supports a morphogenetic program, known as invasive growth, taking place both during embryogenesis and adulthood. In tumors Met is often aberrantly activated, giving rise to the pathological counterpart of the invasive growth program: cancer progression towards metastasis. Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met. |
Mendeley readers
The data shown below were compiled from readership statistics for 145 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| United States | 1 | <1% |
| Austria | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 141 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 31 | 21% |
| Researcher | 25 | 17% |
| Student > Master | 23 | 16% |
| Student > Bachelor | 15 | 10% |
| Professor > Associate Professor | 8 | 6% |
| Other | 18 | 12% |
| Unknown | 25 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 47 | 32% |
| Medicine and Dentistry | 26 | 18% |
| Biochemistry, Genetics and Molecular Biology | 25 | 17% |
| Chemistry | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 8 | 6% |
| Unknown | 26 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2022.
All research outputs
#4,696,096
of 22,786,087 outputs
Outputs from Cancer and Metastasis Reviews
#130
of 807 outputs
Outputs of similar age
#22,105
of 156,082 outputs
Outputs of similar age from Cancer and Metastasis Reviews
#2
of 11 outputs
Altmetric has tracked 22,786,087 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 807 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.